Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CHA Health Systems operates a global network of hospitals and clinics with a strong reputation in women’s health services and advanced therapies using cord blood stem cells and immune cells. The group has established research centers focused on developing new drugs and medical technologies for incurable diseases. It also runs a Global Stem Cell Clinical Trials Center to advance its capabilities in new drug development[2][5]. A contract development and manufacturing organization (CDMO) facility for gene and cell therapies was scheduled to be completed by 2024[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CHA Health Systems.